Novel therapy delays muscle atrophy in Lou Gehrig’s disease model

Share on facebook
Share on twitter
Share on pinterest

Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig’s disease, according to a new study. Researchers found high levels of the protein — called mitofusion 2 or Mfn2 — prevented nerve degeneration, muscle atrophy, and paralysis in a mouse model of the disease. Since Mfn2 is often depleted during Lou Gehrig’s, the new study suggests supplementing it could be a novel therapeutic approach for the disease.

from Latest Science News — ScienceDaily https://ift.tt/2LaWjau
via IFTTT

Subscribe to our Newsletter

Subscribe now to stay up to date on news and upcoming events. 

Share this post with your friends

Share on facebook
Share on google
Share on twitter
Share on linkedin

Leave a Reply

Your email address will not be published. Required fields are marked *